107 related articles for article (PubMed ID: 9562039)
1. Antigenic homology of HIV-1 GP41 and human platelet glycoprotein GPIIIa (integrin beta3).
Dominguez V; Gevorkian G; Govezensky T; Rodriguez H; Viveros M; Cocho G; Macotela Y; Masso F; Pacheco M; Estrada JL; Lavalle C; Larralde C
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr; 17(5):385-90. PubMed ID: 9562039
[TBL] [Abstract][Full Text] [Related]
2. Cross-reactive antibodies between HIV-gp120 and platelet gpIIIa (CD61) in HIV-related immune thrombocytopenic purpura.
Bettaieb A; Oksenhendler E; Duedari N; Bierling P
Clin Exp Immunol; 1996 Jan; 103(1):19-23. PubMed ID: 8565280
[TBL] [Abstract][Full Text] [Related]
3. Structural homology of HIV-1 GP41 and human platelet glycoprotein GPIIIa.
Wiwanitkit V
Blood Coagul Fibrinolysis; 2008 Oct; 19(7):739-740. PubMed ID: 18832897
[No Abstract] [Full Text] [Related]
4. GPIIIa-(49-66) is a major pathophysiologically relevant antigenic determinant for anti-platelet GPIIIa of HIV-1-related immunologic thrombocytopenia.
Nardi MA; Liu LX; Karpatkin S
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7589-94. PubMed ID: 9207136
[TBL] [Abstract][Full Text] [Related]
5. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
[TBL] [Abstract][Full Text] [Related]
6. Antigenic activity of three chimeric synthetic peptides of the transmembrane (gp41) and the envelope (gp120) glycoproteins of HIV-1 virus.
Marin MH; Peña LP; Tanty CR; Higginson Clarke D; Arenas MA; Noguerol KR; León CS
Prep Biochem Biotechnol; 2004 Aug; 34(3):227-37. PubMed ID: 15461139
[TBL] [Abstract][Full Text] [Related]
7. Vertical transmission of human immunodeficiency virus type 1: seroreactivity by maternal antibodies to the carboxy region of the gp41 envelope glycoprotein.
Ugen KE; Srikantan V; Goedert JJ; Nelson RP; Williams WV; Weiner DB
J Infect Dis; 1997 Jan; 175(1):63-9. PubMed ID: 8985197
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
[TBL] [Abstract][Full Text] [Related]
9. A cocktail of thermally stable, chemically synthesized capture agents for the efficient detection of anti-gp41 antibodies from human sera.
Pfeilsticker JA; Umeda A; Farrow B; Hsueh CL; Deyle KM; Kim JT; Lai BT; Heath JR
PLoS One; 2013; 8(10):e76224. PubMed ID: 24116098
[TBL] [Abstract][Full Text] [Related]
10. A survey of synthetic HIV-1 peptides with natural and chimeric sequences for differential reactivity with Zimbabwean, Tanzanian and Swedish HIV-1-positive sera.
Blomberg J; Lawoko A; Pipkorn R; Moyo S; Malmvall BE; Shao J; Dash R; Tswana S
AIDS; 1993 Jun; 7(6):759-67. PubMed ID: 8363754
[TBL] [Abstract][Full Text] [Related]
11. Early fall of antibodies against the motif 583-599 of gp41 in the sera of individuals with HIV-1 infection.
Echaniz P; Sola MD; Cuadrado E
Vox Sang; 1994; 66(1):86-7. PubMed ID: 7511854
[No Abstract] [Full Text] [Related]
12. [Construction of peptide mimetics of an epitope of the human immunodeficiency virus (HIV-1) gp41 protein, recognized by virus-neutralizing antibodies 2F5].
Tumanova OIu; Kuvshinov VN; Azaev MSh; Masharskiĭ AE; Klimov NA; Kozlov AP; Il'ichev AA; Sandakhchiev LS
Mol Biol (Mosk); 2001; 35(1):146-51. PubMed ID: 11234374
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
[TBL] [Abstract][Full Text] [Related]
14. Production and characterization of human monoclonal antibodies against core protein p25 and transmembrane glycoprotein gp41 of HIV-1.
Prigent S; Goossens D; Clerget-Raslain B; Bahraoui E; Roussel M; Tsikas G; Laurent A; Montagnier L; Salmon C; Gluckman JC
AIDS; 1990 Jan; 4(1):11-9. PubMed ID: 2156527
[TBL] [Abstract][Full Text] [Related]
15. Role of molecular mimicry to HIV-1 peptides in HIV-1-related immunologic thrombocytopenia.
Li Z; Nardi MA; Karpatkin S
Blood; 2005 Jul; 106(2):572-6. PubMed ID: 15774614
[TBL] [Abstract][Full Text] [Related]
16. Antibody responses to HIV-1 envelope and gag epitopes in HIV-1 seroconverters with rapid versus slow disease progression.
Zwart G; van der Hoek L; Valk M; Cornelissen MT; Baan E; Dekker J; Koot M; Kuiken CL; Goudsmit J
Virology; 1994 Jun; 201(2):285-93. PubMed ID: 7514319
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptides and anti-peptide antibodies as probes to study interdomain interactions involved in virus assembly: the envelope of the human immunodeficiency virus (HIV-1).
Neurath AR; Strick N; Jiang S
Virology; 1992 May; 188(1):1-13. PubMed ID: 1373549
[TBL] [Abstract][Full Text] [Related]
18. ELNKWA-epitope specific antibodies induced by epitope-vaccine recognize ELDKWA- and other two neutralizing-resistant mutated epitopes on HIV-1 gp41.
Dong XN; Xiao Y; Chen YH
Immunol Lett; 2001 Jan; 75(2):149-52. PubMed ID: 11137140
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of antibodies against interferon-alpha in HIV-1 positive individuals may be explained by a common immunological epitope on the human interferon-alpha and HIV-1 gp41.
Chen YH; Stoiber H; Dierich MP
Immunol Lett; 1997 Jan; 55(1):15-8. PubMed ID: 9093876
[TBL] [Abstract][Full Text] [Related]
20. Rapid "tea-bag" peptide synthesis using 9-fluorenylmethoxycarbonyl (Fmoc) protected amino acids applied for antigenic mapping of viral proteins.
Sällberg M; Rudén U; Magnius LO; Norrby E; Wahren B
Immunol Lett; 1991 Sep; 30(1):59-68. PubMed ID: 1720419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
